THE

Republic First Bancorp, Inc. Comments on the Norcross Group’s Latest 13D Filing

Retrieved on: 
Monday, October 24, 2022
U.S. Securities and Exchange Commission, SEC, Mission statement, Schedule 13D, NDA, Standstill, THE, Annual report, Board of directors, NASDAQ, Bank, Republic First Bancorp, Security (finance), Annual general meeting, Private Securities Litigation Reform Act, Black, III, Goal, Dragon, Republic Bank, Company, Federal Deposit Insurance Corporation, Norcross, ATM, Board, Committee, CEO, Dragon (magazine), Interview, GLOBE, NDAS, FDIC, CARD, ALL, Trustee, Management, Risk management

PHILADELPHIA, Oct. 24, 2022 (GLOBE NEWSWIRE) -- The Board of Directors (the “Board”) of Republic First Bancorp, Inc. (NASDAQ: FRBK) (the “Company”), the holding company for Republic First Bank d/b/a Republic Bank, today issued the following statement in response to the October 21, 2022 amended Schedule 13D filing and accompanying demand letter (the “Norcross Filing”) issued by George E. Norcross, III, Gregory B. Braca, Philip A. Norcross and Avery Conner Capital Trust and its trustees (collectively, and together with their respective affiliates, the “Norcross Group”):

Key Points: 
  • The Norcross Groups repeated claims that its principals have been ignored by the Board are utterly false.
  • Indeed, the Norcross Group has had access to the full Board, through the Norcross Groups advisors, as well as regular dialogue with individual directors (directly and through advisors).
  • The Norcross Groups harmful behavior patterns call into question how George Norcross and the Norcross Groups actions might reflect on the Company and affect the Companys employees and the communities that the Company serves.
  • Republic First Bancorp, Inc. is the holding company for Republic First Bank, which does business under the name Republic Bank.

East Stone Acquisition Corporation Announces Filing and Mailing of Definitive Proxy Statement and November 7 Special Meeting to Approve Business Combination with NTWN Inc.

Retrieved on: 
Monday, October 24, 2022
Transfer, EAST, Virgin Islands, Registration statement, Nasdaq, Transport, ICONIQ, Courage, Alan, Securities Act of 1933, Failure, Business architecture, IOT, Telephone, WHEN, Attempted purchase of Time Warner Cable by Comcast, THE, Investment, Private Securities Litigation Reform Act, Company, GLOBE, Special, Trust, Suite, Risk, Growth, Register, Research, Annual report, Technology, Form 10-K, Probability, DWAC, PARTIES, SPECIAL, 1345 Avenue of the Americas, Prospectus, Combination, U.S. Securities and Exchange Commission, Sale, SEC, Acquisition, Information technology, Form, Forward-looking statement, Sherman, COVID-19, Management, Security (finance), Transaction, Tregeseal East stone circle

The Merger Proxy Statement and related materials are being delivered today to holders of record as of October 4, 2022.

Key Points: 
  • The Merger Proxy Statement and related materials are being delivered today to holders of record as of October 4, 2022.
  • Holders of East Stone ordinary shares at the close of business on the record date ofOctober 4, 2022are entitled to notice of, and to vote at, the Special Meeting.
  • East Stone shareholders who need assistance voting or have questions regarding the Special Meeting may contact East Stones proxy solicitor, Morrow Sodali, by telephone at 800-662-5200 or by email [email protected].
  • The definitive proxy statement and other relevant documents are being mailed to shareholders of East Stone as of a record date of October 4, 2022.

ASFV Committee Reveals Troubling Statements Made by Entrenched AIM Board Uncovered Through Discovery in Delaware Action

Retrieved on: 
Monday, October 24, 2022
U.S. Securities and Exchange Commission, Time, Use, Mitchell, SEC, ASFV, THE, NYSE, General counsel, Lagos State Ministry of Tourism and Inter-governmental Relations, Patient, Corporation, Security (finance), Private practice, AIM, Annual general meeting, NUALS Arts and Literary Annual Meet, GOLD, Company, Board, Board of directors, GLOBE, Human back, Participation, COVID-19, Consultant, Audit, Holding company, Pharmaceutical industry, Management, Real estate, Online gambling

We believe the entrenched AIM Boards statements about stockholders, expectation for excessive compensation, and tactics to deny any stockholder nomination are truly reprehensible, stated the ASFV Committee.

Key Points: 
  • We believe the entrenched AIM Boards statements about stockholders, expectation for excessive compensation, and tactics to deny any stockholder nomination are truly reprehensible, stated the ASFV Committee.
  • The Boards actions, before the ASFV nomination and since, clearly demonstrate that they are breaching their fiduciary duties to the Company and its stockholders.
  • We believe it is clear that this entrenched Board is not putting the interests of the Company and its stockholders first in making decisions and evaluating opportunities.
  • Notwithstanding the foregoing, the incumbent Board members have never once considered expanding the Board or hiring executives with relevant experience to help run AIM.

Sumitovant Biopharma, Sumitomo Pharma, and Myovant Sciences Enter into Definitive Agreement

Retrieved on: 
Monday, October 24, 2022
Slate, Skadden, Reading, CEO, Pediatrics, LLP, Communication, Roivant Sciences, THE, NYSE, AND, Report of the Special Committee on the Termination of the National Emergency, Company, Committee, GLOBE, FDA, Risk, New, Growth, Woman, Hand, Â, Special, Oliver Cromwell, Board, Prostate cancer, Goldman Sachs, Schedule, Sullivan & Cromwell, U.S. Securities and Exchange Commission, SEC, Schedule 13D, Sumitomo Mitsui Banking Corporation, Patient, Biotechnology, Man, Urology, Acquisition, Health, Form, Forward-looking statement, COVID-19, Security (finance), Fine chemical, Risk management, Pharmaceutical industry, Management

NEW YORK and BASEL, Switzerland and OSAKA, Japan, Oct. 23, 2022 (GLOBE NEWSWIRE) -- Sumitovant Biopharma Ltd. (“Sumitovant”), in conjunction with parent company Sumitomo Pharma Co., Ltd. (“Sumitomo Pharma”), and Myovant Sciences (“Myovant”) (NYSE: MYOV) announced today that they have entered into a definitive agreement pursuant to which Sumitovant will acquire all outstanding shares of Myovant not already owned by Sumitovant for $27.00 per share in cash. This corresponds to a total transaction value of $1.7 billion on a fully diluted basis, and a total company value of $2.9 billion on a fully diluted basis. Sumitovant currently beneficially owns 52% of the issued and outstanding shares of Myovant as more particularly described in Sumitovant’s Schedule 13D/A filed with the U.S. Securities and Exchange Commission (the “SEC”).

Key Points: 
  • NEW YORK and BASEL, Switzerland and OSAKA, Japan, Oct. 23, 2022 (GLOBE NEWSWIRE) -- Sumitovant Biopharma Ltd. (Sumitovant), in conjunction with parent company Sumitomo Pharma Co., Ltd. (Sumitomo Pharma), and Myovant Sciences (Myovant) (NYSE: MYOV) announced today that they have entered into a definitive agreement pursuant to which Sumitovant will acquire all outstanding shares of Myovant not already owned by Sumitovant for $27.00 per share in cash.
  • We are pleased to have reached an agreement with Sumitovant and Sumitomo Pharma that recognizes the remarkable success Myovant has achieved, said David Marek, CEO of Myovant.
  • This communication contains forward-looking statements, including statements regarding expectations about the proposed transaction involving Myovant, Sumitovant and Sumitomo Pharma.
  • Myovant, Sumitovant and Sumitomo Pharma disclaim any obligation to update these forward-looking statements, except as may be required.

ROSEN, A LEADING LAW FIRM, Encourages Palantir Technologies Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – PLTR

Retrieved on: 
Sunday, October 23, 2022
Titan, LinkedIn, Advertising, Government, Class, Growth, THE, NYSE, Twitter, Court, Investment, Facebook, EPS, WHY, PLTR, TO, Lists of schools in England, I-Space (Chinese company), Insurance, Tobacco, Palantir Technologies

WHAT TO DO NEXT: To join the Palantir class action, go to https://rosenlegal.com/submit-form/?case_id=8711 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Palantir class action, go to https://rosenlegal.com/submit-form/?case_id=8711 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ROSEN, LEADING INVESTOR COUNSEL, Encourages Schmitt Industries, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – SMIT

Retrieved on: 
Sunday, October 23, 2022
Titan, LinkedIn, Advertising, Mission statement, Class, THE, NASDAQ, Twitter, Court, Company, Facebook, WHY, TO, Lists of schools in England, GLOBE, SMIT, I-Space (Chinese company), Insurance, Tobacco

WHAT TO DO NEXT: To join the Schmitt Industries class action, go to https://rosenlegal.com/submit-form/?case_id=8823 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Schmitt Industries class action, go to https://rosenlegal.com/submit-form/?case_id=8823 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

SFIX DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Stitch Fix, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 25 Deadline in Securities Class Action – SFIX

Retrieved on: 
Sunday, October 23, 2022
Titan, LinkedIn, Advertising, Class, THE, NASDAQ, Twitter, Court, Stitch, Facebook, WHY, Fix, TO, Lists of schools in England, GLOBE, I-Space (Chinese company), Security (finance), Health insurance, Tobacco, Stitch Fix

WHAT TO DO NEXT: To join the Stitch Fix class action, go to https://rosenlegal.com/submit-form/?case_id=8552 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Stitch Fix class action, go to https://rosenlegal.com/submit-form/?case_id=8552 or call Phillip Kim, Esq.
  • If you wish to serve as lead plaintiff, you must move the Court no later than October 25, 2022.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ROSEN, A TOP RANKED LAW FIRM, Encourages Olo Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – OLO

Retrieved on: 
Sunday, October 23, 2022
Titan, LinkedIn, Globe, Advertising, Class, THE, NYSE, Twitter, Court, OLO, Facebook, WHY, TO, Lists of schools in England, GLOBE, I-Space (Chinese company), Insurance, Tobacco

WHAT TO DO NEXT: To join the Olo class action, go to https://rosenlegal.com/submit-form/?case_id=8131 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Olo class action, go to https://rosenlegal.com/submit-form/?case_id=8131 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Kohl’s Corporation Investors with Losses Exceeding $100K to Secure Counsel Before Important November 1 Deadline in Securities Class Action – KSS

Retrieved on: 
Sunday, October 23, 2022
Titan, LinkedIn, Advertising, Class, THE, NYSE, Twitter, Court, Facebook, Company, KSS, WHY, TO, Lists of schools in England, Disclosure, I-Space (Chinese company), Online gambling, Insurance, Tobacco

WHAT TO DO NEXT: To join the Kohls class action, go to https://rosenlegal.com/submit-form/?case_id=8539 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Kohls class action, go to https://rosenlegal.com/submit-form/?case_id=8539 or call Phillip Kim, Esq.
  • toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ROSEN, LEADING INVESTOR COUNSEL, Encourages Medtronic plc Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – MDT

Retrieved on: 
Sunday, October 23, 2022
Titan, LinkedIn, Advertising, Risk, Risk assessment, Class, THE, NYSE, Regulation of tobacco by the U.S. Food and Drug Administration, Twitter, MDT, Court, Facebook, Food, WHY, TO, Lists of schools in England, GLOBE, I-Space (Chinese company), Insurance, Tobacco, Medtronic

WHAT TO DO NEXT: To join the Medtronic class action, go to https://rosenlegal.com/submit-form/?case_id=8603 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Medtronic class action, go to https://rosenlegal.com/submit-form/?case_id=8603 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.